Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Every day, billions of mobile and Internet-enabled computers, smartphones, watches, drones and even coffee machines are collecting vast amounts of geolocation data about their users. Apps such as Foursquare, Tinder and Waze, as well as mobile games such as Pokemon Go and Zombies Run all track and reveal an individual’s physical location through GPS, Wi-Fi and cell-based tracking technologies. This information, in turn, can be used to market products and services, deliver context-specific content, monitor users or employees, and enforce location-based access restrictions, providing valuable information to companies that can help them uncover new insights about consumers and their behaviors. While this ubiquitous collection of data can have social and economic benefits, it can also pose significant privacy and security concerns.
*May exclude premium content
Defeating Certification of “No-Injury” Consumer Protection Class Actions
By Steven P. Benenson
In the past several years, plaintiffs’ firms have threatened or brought class actions against different companies under New Jersey’s Truth-in-Consumer Contract Warranty and Notice Act (TCCWNA). Here's what you need to know.
Maximizing Future Medical Damages in Paralysis Cases
By Mitch Warnock
When you take a catastrophic injury case involving paralysis, it is important to have a thorough understanding of the problems and pitfalls. In this article, the author explores, from personal experience, the different types of future expenses the client can expect to incur.
Genetic Labeling: Legal Uncertainty for Pharma Product Liability
By Shannon E. McClure and Whitney Mayer
The FDA’s recent approval of 23andMe’s direct-to-consumer genetic test to identify genes associated with 10 common diseases and disorders could result in a widespread expansion of patients armed with individualized health information. This expansion of genetic information in the hands of consumers potentially impacts regulatory and litigation issues for pharmaceutical companies.
By ljnstaff
Discussion of major rulings out of Texas and California.